FDA Inspection 1127442 — Georgios Papatheodoridis, M.D.

Georgios Papatheodoridis, M.D. — FEI 3013185677

The FDA completed an inspection of Georgios Papatheodoridis, M.D. on Mar 16, 2017 in Athens, Attiki 11527. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 16, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Athens, Attiki 11527 (Greece)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.